Announcement on Holding the Performance Briefing for Q3 2024
Filed with SSE · · 2 pages · Chinese
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
- Announcement on the Second Unlocking of Restricted Stock Involved in the 2022 Restricted Stock Incentive Plan
- Announcement on Obtaining the Drug Registration Certificate
- 2024 Semi-annual Report Full Text
- Announcement on Convening Semi-annual Performance Briefing 2024
Later from Jianmin Pharmaceutical
- Announcement on Election of Director to Act as Chairman
- Notice on Convening the 2nd Extraordinary General Meeting in 2024
- Announcement on Inclusion and Renewal of the Company's Products on the Catalogue of Drugs for Basic National Medical Insurance (2024)
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Announcement on Resolution of the 30th Meeting of the 10th Board of Directors
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical